* [PATCH](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30392-0/fulltext) (2016)
	* 190 European adults on antiplatelet therapy with supratentorial non-traumatic, non-aneurysmal ICH and a GCS from 8-15, without intraventicular haemorrhage, history of coagulopathy
	* Multicentre (41), assessor blinded RCT
	* 91% power to detect OR of 0.43 (!) between pairs of mRS categories
	* Platelets vs. standard care
		* Platelets
			* 5 units if on COX inhibitor
			* 10 units if on ADP receptor inhibitor
			* 4 did not receive platelets
		* Control
			* 2 received platelets
	* Worse functional outcome at 3 months (OR ~2, CI 1.2-3.6)

:::column-margin
![](/resources/patch.png)
:::